Home

Michael Halstead

CIK 1521548 · President · last filed 2025-04-02

Michael Halstead is a President who has filed 61 SEC Form 4 insider transactions across 1 company since 2014. The most recent filing, for ITCI, was dated Apr 2, 2025. Across all open-market trades the lifetime net is −$33.1M, making them a net seller over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

1

Total Filings

61

Lifetime Open-Market Net

-$33.09M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Intra-Cellular Therapies, Inc. (ITCI) Delisted President 0 $131.87 $0 -$33.09M 43 2025-04-02

Recent Filings

61 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-04-02 Intra-Cellular Therapies, Inc. (ITCI) Delisted Mixed −21,307 -$2.81M EDGAR
2025-03-10 Intra-Cellular Therapies, Inc. (ITCI) Delisted Mixed +10,003 -$1.37M EDGAR
2025-03-04 Intra-Cellular Therapies, Inc. (ITCI) Delisted Mixed +5,978 -$802.7K EDGAR
2025-02-04 Intra-Cellular Therapies, Inc. (ITCI) Delisted Mixed +5,326 -$722.8K EDGAR
2024-11-14 Intra-Cellular Therapies, Inc. (ITCI) Delisted Mixed — -$2.45M EDGAR
2024-03-11 Intra-Cellular Therapies, Inc. (ITCI) Delisted Mixed −13,132 -$1.35M EDGAR
2024-03-08 Intra-Cellular Therapies, Inc. (ITCI) Delisted Exer (M) +13,132 $0 EDGAR
2024-03-05 Intra-Cellular Therapies, Inc. (ITCI) Delisted Grant (A) — $0 EDGAR
2024-02-27 Intra-Cellular Therapies, Inc. (ITCI) Delisted Mixed — -$549.8K EDGAR
2024-02-05 Intra-Cellular Therapies, Inc. (ITCI) Delisted Mixed — -$787.7K EDGAR
Showing 1–10 of 61
Page 1 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.